Female Aedes aegypti mosquitoes infect more than 400 million people each year with
dangerous viral pathogens including dengue, yellow fever, Zika and chikungunya. Progress in …

Background Aedes aegypti, the ‘yellow fever mosquito’, is the primary vector to humans of
dengue and yellow fever flaviviruses (DENV, YFV), and is a known vector of the chikungunya …

Background Worldwide the mosquito Aedes aegypti (L.) is the principal urban vector of dengue
viruses. Currently 2.5 billion people are at risk for infection and reduction of Ae. aegypti …

Aedes aegypti is the primary urban mosquito vector of viruses causing dengue, Zika and
chikungunya fevers –for which vaccines and effective pharmaceuticals are still lacking. Current …

The mosquito Aedes aegypti is the principal vector of dengue and yellow fever flaviviruses.
Permethrin is an insecticide used to suppress Ae. aegypti adult populations but metabolic …

Abstract Changes in gene expression before, during and after five generations of permethrin
laboratory selection were monitored in six strains of Aedes aegypti: five F 2 –F 3 collections …

BACKGROUND The V1016I and F1534C mutations in the voltage‐gated sodium channel
gene have been associated with resistance to pyrethroids and DDT in Aedes aegypti …

The emergence of novel diseases spread by the Aedes aegypti mosquito in Jamaica and the
Caribbean, has prompted studies on insecticide resistance towards effective management …

Dengue fever and its more serious complications dengue haemorrhagic fever and dengue
shock syndrome are growing public health problems in tropical and subtropical countries. In …

The mosquito Aedes aegypti is the major vector of the four serotypes of dengue virus (DENV1–4).
Previous studies have shown that Ae. aegypti in Mexico have a high effective …